 Michael Schurr
Concepts (381)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pseudomonas aeruginosa | 56 | 2025 | 352 | 6.230 |
Why?
| | Gene Expression Regulation, Bacterial | 32 | 2018 | 328 | 3.920 |
Why?
| | Bacterial Proteins | 34 | 2019 | 879 | 3.310 |
Why?
| | Trans-Activators | 11 | 2018 | 398 | 2.620 |
Why?
| | Corynebacterium Infections | 6 | 2024 | 41 | 2.290 |
Why?
| | Corynebacterium | 7 | 2024 | 49 | 2.250 |
Why?
| | Pseudomonas Infections | 16 | 2025 | 225 | 1.770 |
Why?
| | Biofilms | 19 | 2021 | 260 | 1.700 |
Why?
| | Alginates | 19 | 2020 | 46 | 1.580 |
Why?
| | Sigma Factor | 16 | 2013 | 40 | 1.090 |
Why?
| | Transcription, Genetic | 18 | 2014 | 1457 | 1.040 |
Why?
| | Mice, Nude | 4 | 2024 | 698 | 1.020 |
Why?
| | Cell-Penetrating Peptides | 1 | 2025 | 21 | 0.920 |
Why?
| | Anti-Bacterial Agents | 12 | 2025 | 1809 | 0.920 |
Why?
| | Gentamicins | 1 | 2025 | 54 | 0.900 |
Why?
| | Cystic Fibrosis | 19 | 2020 | 1114 | 0.900 |
Why?
| | Regulon | 5 | 2014 | 36 | 0.790 |
Why?
| | Urinary Tract Infections | 1 | 2025 | 188 | 0.780 |
Why?
| | Drug Delivery Systems | 1 | 2025 | 365 | 0.730 |
Why?
| | Lasers, Solid-State | 1 | 2021 | 22 | 0.710 |
Why?
| | Titanium | 1 | 2021 | 82 | 0.690 |
Why?
| | Transcription Factors | 10 | 2014 | 1719 | 0.600 |
Why?
| | Pyocyanine | 1 | 2018 | 2 | 0.580 |
Why?
| | Protein Processing, Post-Translational | 2 | 2018 | 465 | 0.560 |
Why?
| | Staphylococcus aureus | 2 | 2023 | 450 | 0.520 |
Why?
| | Genes, Bacterial | 15 | 2010 | 164 | 0.500 |
Why?
| | Oligopeptides | 1 | 2018 | 271 | 0.490 |
Why?
| | Nitrites | 6 | 2021 | 84 | 0.470 |
Why?
| | Mice | 22 | 2025 | 17787 | 0.460 |
Why?
| | Promoter Regions, Genetic | 11 | 2014 | 1250 | 0.430 |
Why?
| | Quorum Sensing | 5 | 2016 | 77 | 0.410 |
Why?
| | Glycolipids | 1 | 2013 | 42 | 0.410 |
Why?
| | Mice, Inbred NOD | 4 | 2023 | 601 | 0.410 |
Why?
| | Bacteria | 4 | 2020 | 858 | 0.400 |
Why?
| | Culture Media | 5 | 2024 | 165 | 0.390 |
Why?
| | Locomotion | 1 | 2013 | 106 | 0.390 |
Why?
| | Gene Expression Profiling | 10 | 2018 | 1774 | 0.380 |
Why?
| | Virulence | 10 | 2018 | 267 | 0.370 |
Why?
| | Molecular Sequence Data | 19 | 2014 | 2900 | 0.350 |
Why?
| | Composite Resins | 2 | 2021 | 110 | 0.340 |
Why?
| | Edetic Acid | 2 | 2021 | 50 | 0.340 |
Why?
| | Heat-Shock Response | 3 | 2013 | 77 | 0.340 |
Why?
| | Animals | 27 | 2025 | 36940 | 0.340 |
Why?
| | Coinfection | 2 | 2023 | 137 | 0.330 |
Why?
| | Base Sequence | 15 | 2014 | 2181 | 0.330 |
Why?
| | Disinfectants | 2 | 2021 | 39 | 0.320 |
Why?
| | Oligonucleotide Array Sequence Analysis | 6 | 2013 | 767 | 0.310 |
Why?
| | Hexosyltransferases | 2 | 2010 | 5 | 0.300 |
Why?
| | DNA-Binding Proteins | 5 | 2009 | 1502 | 0.300 |
Why?
| | Epithelial Cells | 3 | 2006 | 1096 | 0.300 |
Why?
| | Cryoprotective Agents | 1 | 2008 | 10 | 0.290 |
Why?
| | Cyanides | 1 | 2009 | 52 | 0.290 |
Why?
| | Skin Diseases | 2 | 2023 | 149 | 0.280 |
Why?
| | Microbial Viability | 1 | 2008 | 91 | 0.280 |
Why?
| | Gene Deletion | 6 | 2013 | 391 | 0.270 |
Why?
| | Milk | 1 | 2008 | 124 | 0.270 |
Why?
| | Repressor Proteins | 3 | 2009 | 427 | 0.270 |
Why?
| | Cryopreservation | 1 | 2008 | 100 | 0.270 |
Why?
| | Staphylococcal Infections | 2 | 2023 | 400 | 0.260 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2021 | 195 | 0.260 |
Why?
| | Phosphorylation | 4 | 2018 | 1759 | 0.250 |
Why?
| | Mice, SCID | 2 | 2023 | 367 | 0.230 |
Why?
| | Re-Epithelialization | 3 | 2021 | 7 | 0.230 |
Why?
| | Hydrogen Cyanide | 1 | 2004 | 5 | 0.230 |
Why?
| | Disease Models, Animal | 6 | 2024 | 4295 | 0.230 |
Why?
| | Space Flight | 3 | 2010 | 87 | 0.220 |
Why?
| | Burns | 2 | 2019 | 325 | 0.220 |
Why?
| | Hexuronic Acids | 11 | 2014 | 23 | 0.220 |
Why?
| | Lung | 5 | 2019 | 4060 | 0.220 |
Why?
| | Glucuronic Acid | 11 | 2014 | 25 | 0.220 |
Why?
| | Transcription Initiation Site | 3 | 2014 | 43 | 0.220 |
Why?
| | Bacterial Adhesion | 3 | 2019 | 100 | 0.200 |
Why?
| | Respiratory System | 1 | 2004 | 157 | 0.200 |
Why?
| | Azo Compounds | 2 | 2021 | 30 | 0.200 |
Why?
| | Rodentia | 2 | 2021 | 57 | 0.190 |
Why?
| | Streptococcus mutans | 1 | 2021 | 8 | 0.190 |
Why?
| | Dental Bonding | 1 | 2021 | 33 | 0.180 |
Why?
| | Sodium Nitrite | 2 | 2020 | 39 | 0.180 |
Why?
| | Aggregatibacter actinomycetemcomitans | 1 | 2021 | 27 | 0.180 |
Why?
| | Acinetobacter Infections | 1 | 2021 | 14 | 0.180 |
Why?
| | DNA, Bacterial | 4 | 2014 | 337 | 0.180 |
Why?
| | Coated Materials, Biocompatible | 2 | 2019 | 62 | 0.180 |
Why?
| | Acinetobacter baumannii | 1 | 2021 | 21 | 0.180 |
Why?
| | Iron | 4 | 2014 | 313 | 0.170 |
Why?
| | Drinking Water | 1 | 2022 | 84 | 0.170 |
Why?
| | Wound Infection | 1 | 2021 | 32 | 0.170 |
Why?
| | Epidermal Growth Factor | 1 | 2021 | 177 | 0.170 |
Why?
| | Wilderness | 1 | 2020 | 16 | 0.170 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2021 | 78 | 0.170 |
Why?
| | Iraq War, 2003-2011 | 1 | 2021 | 127 | 0.170 |
Why?
| | Mountaineering | 1 | 2020 | 40 | 0.170 |
Why?
| | Afghan Campaign 2001- | 1 | 2021 | 132 | 0.170 |
Why?
| | Surface Properties | 1 | 2021 | 413 | 0.160 |
Why?
| | Microbial Interactions | 1 | 2020 | 18 | 0.160 |
Why?
| | Microarray Analysis | 2 | 2018 | 117 | 0.160 |
Why?
| | Chlorine Compounds | 1 | 2019 | 10 | 0.160 |
Why?
| | Skin, Artificial | 1 | 2019 | 4 | 0.160 |
Why?
| | Wound Healing | 3 | 2021 | 331 | 0.160 |
Why?
| | Decontamination | 1 | 2019 | 30 | 0.160 |
Why?
| | Oxides | 1 | 2019 | 46 | 0.160 |
Why?
| | Heat-Shock Proteins | 2 | 1997 | 143 | 0.150 |
Why?
| | Metabolic Networks and Pathways | 3 | 2020 | 180 | 0.150 |
Why?
| | Skin Transplantation | 1 | 2019 | 85 | 0.150 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2019 | 61 | 0.140 |
Why?
| | Accidental Falls | 1 | 2020 | 196 | 0.140 |
Why?
| | Mutation | 8 | 2019 | 3958 | 0.140 |
Why?
| | Amino Acid Sequence | 11 | 2011 | 2139 | 0.140 |
Why?
| | Models, Biological | 1 | 2005 | 1783 | 0.140 |
Why?
| | Operon | 2 | 2009 | 64 | 0.130 |
Why?
| | Humans | 31 | 2025 | 137585 | 0.130 |
Why?
| | Gene Conversion | 1 | 1996 | 7 | 0.130 |
Why?
| | Aspergillus | 1 | 2016 | 17 | 0.130 |
Why?
| | Age Factors | 1 | 2024 | 3295 | 0.130 |
Why?
| | Amidohydrolases | 1 | 2016 | 31 | 0.130 |
Why?
| | Polyurethanes | 1 | 2016 | 38 | 0.120 |
Why?
| | Multigene Family | 4 | 1994 | 198 | 0.120 |
Why?
| | Gallium | 1 | 2015 | 5 | 0.120 |
Why?
| | Severity of Illness Index | 1 | 2024 | 2828 | 0.120 |
Why?
| | Drosophila melanogaster | 1 | 2018 | 233 | 0.120 |
Why?
| | Nitric Oxide | 2 | 2014 | 915 | 0.120 |
Why?
| | Intubation, Intratracheal | 1 | 2018 | 257 | 0.120 |
Why?
| | Aspartate Carbamoyltransferase | 1 | 1995 | 2 | 0.120 |
Why?
| | Dihydroorotase | 1 | 1995 | 2 | 0.120 |
Why?
| | Pseudomonas putida | 1 | 1995 | 3 | 0.120 |
Why?
| | Microbial Sensitivity Tests | 4 | 2021 | 361 | 0.120 |
Why?
| | Gastrointestinal Microbiome | 1 | 2023 | 697 | 0.120 |
Why?
| | Tissue Engineering | 1 | 2019 | 423 | 0.120 |
Why?
| | Phenotype | 9 | 2014 | 3196 | 0.120 |
Why?
| | Oxidoreductases Acting on CH-NH2 Group Donors | 2 | 2004 | 2 | 0.110 |
Why?
| | Proto-Oncogene Proteins c-sis | 1 | 2014 | 39 | 0.110 |
Why?
| | Splints | 1 | 2014 | 15 | 0.110 |
Why?
| | Multienzyme Complexes | 2 | 2004 | 68 | 0.110 |
Why?
| | Polysaccharides, Bacterial | 2 | 2014 | 70 | 0.110 |
Why?
| | Escherichia coli | 5 | 1996 | 815 | 0.110 |
Why?
| | Oxidoreductases | 2 | 2004 | 92 | 0.110 |
Why?
| | Catalase | 1 | 2014 | 130 | 0.110 |
Why?
| | Microbiota | 1 | 2022 | 762 | 0.110 |
Why?
| | Patient Selection | 1 | 2018 | 696 | 0.110 |
Why?
| | Cyclic GMP | 1 | 2014 | 93 | 0.110 |
Why?
| | Flagella | 2 | 2011 | 27 | 0.110 |
Why?
| | Host Factor 1 Protein | 2 | 2010 | 4 | 0.110 |
Why?
| | Fimbriae Proteins | 1 | 2013 | 21 | 0.110 |
Why?
| | Athletic Injuries | 1 | 2020 | 529 | 0.110 |
Why?
| | RNA Polymerase Sigma 54 | 2 | 2011 | 3 | 0.110 |
Why?
| | Vanadates | 1 | 2013 | 14 | 0.100 |
Why?
| | Drug Resistance, Bacterial | 3 | 2020 | 186 | 0.100 |
Why?
| | DNA-Directed RNA Polymerases | 3 | 2000 | 57 | 0.100 |
Why?
| | Mutant Proteins | 1 | 2013 | 103 | 0.100 |
Why?
| | Respiration, Artificial | 1 | 2018 | 645 | 0.100 |
Why?
| | Carbohydrate Dehydrogenases | 4 | 2000 | 11 | 0.100 |
Why?
| | Female | 9 | 2025 | 73304 | 0.100 |
Why?
| | Plasmids | 3 | 2007 | 363 | 0.100 |
Why?
| | Peptide Hydrolases | 1 | 2013 | 111 | 0.100 |
Why?
| | Pyruvic Acid | 1 | 2012 | 53 | 0.100 |
Why?
| | Pseudomonas Phages | 1 | 2011 | 3 | 0.090 |
Why?
| | Bacteriolysis | 1 | 2011 | 9 | 0.090 |
Why?
| | Mutation, Missense | 1 | 2013 | 341 | 0.090 |
Why?
| | Exopeptidases | 1 | 2011 | 1 | 0.090 |
Why?
| | Methacrylates | 2 | 2021 | 117 | 0.090 |
Why?
| | Pulmonary Surfactant-Associated Protein A | 1 | 2011 | 35 | 0.090 |
Why?
| | Cyclic AMP Receptor Protein | 1 | 2010 | 4 | 0.090 |
Why?
| | Weightlessness | 1 | 2010 | 45 | 0.090 |
Why?
| | Cells, Cultured | 4 | 2021 | 4193 | 0.080 |
Why?
| | Materials Testing | 2 | 2021 | 356 | 0.080 |
Why?
| | Salmonella typhimurium | 2 | 2010 | 183 | 0.080 |
Why?
| | Protein Kinases | 1 | 2011 | 319 | 0.080 |
Why?
| | Cyclic AMP | 1 | 2010 | 234 | 0.080 |
Why?
| | DNA Footprinting | 1 | 2009 | 33 | 0.080 |
Why?
| | Anaerobiosis | 4 | 2014 | 64 | 0.080 |
Why?
| | Fimbriae, Bacterial | 2 | 2010 | 34 | 0.070 |
Why?
| | Salmonella | 1 | 2008 | 62 | 0.070 |
Why?
| | Glycerol | 1 | 2008 | 94 | 0.070 |
Why?
| | Virulence Factors | 3 | 2017 | 167 | 0.070 |
Why?
| | Phosphates | 2 | 2008 | 182 | 0.070 |
Why?
| | Proteome | 2 | 2011 | 472 | 0.070 |
Why?
| | Chromosome Mapping | 3 | 1997 | 523 | 0.070 |
Why?
| | DNA, Mitochondrial | 1 | 1988 | 200 | 0.070 |
Why?
| | Polymerase Chain Reaction | 3 | 2021 | 1062 | 0.070 |
Why?
| | Lung Diseases | 3 | 2020 | 767 | 0.070 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 3 | 2008 | 114 | 0.060 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2019 | 560 | 0.060 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2020 | 346 | 0.060 |
Why?
| | Skin | 2 | 2021 | 752 | 0.060 |
Why?
| | Mucin-1 | 1 | 2005 | 21 | 0.060 |
Why?
| | Gene Expression | 3 | 2021 | 1502 | 0.060 |
Why?
| | Bandages | 2 | 2015 | 37 | 0.060 |
Why?
| | Collagen Type IV | 1 | 2005 | 28 | 0.060 |
Why?
| | Laminin | 1 | 2005 | 72 | 0.060 |
Why?
| | Single-Strand Specific DNA and RNA Endonucleases | 1 | 2004 | 10 | 0.060 |
Why?
| | Bioreactors | 1 | 2005 | 42 | 0.060 |
Why?
| | Mucin 5AC | 1 | 2005 | 70 | 0.060 |
Why?
| | Sequence Alignment | 3 | 2011 | 343 | 0.060 |
Why?
| | Tissue Culture Techniques | 1 | 2024 | 78 | 0.060 |
Why?
| | Mucins | 1 | 2005 | 73 | 0.060 |
Why?
| | Electron Transport Complex IV | 1 | 2004 | 60 | 0.060 |
Why?
| | Amoxicillin | 1 | 2023 | 35 | 0.050 |
Why?
| | Down-Regulation | 2 | 2020 | 657 | 0.050 |
Why?
| | Contact Lenses, Hydrophilic | 1 | 2003 | 7 | 0.050 |
Why?
| | Recombinant Fusion Proteins | 2 | 1996 | 665 | 0.050 |
Why?
| | Interleukins | 1 | 2005 | 250 | 0.050 |
Why?
| | Antigens | 1 | 2005 | 357 | 0.050 |
Why?
| | Phosphotransferases (Phosphomutases) | 1 | 2002 | 5 | 0.050 |
Why?
| | Hypochlorous Acid | 1 | 2002 | 8 | 0.050 |
Why?
| | Animal Husbandry | 1 | 2023 | 37 | 0.050 |
Why?
| | Glycoproteins | 1 | 2005 | 342 | 0.050 |
Why?
| | Glucose Oxidase | 1 | 2002 | 26 | 0.050 |
Why?
| | Ammonia | 1 | 2023 | 62 | 0.050 |
Why?
| | Sanitation | 1 | 2023 | 55 | 0.050 |
Why?
| | Housing, Animal | 1 | 2023 | 46 | 0.050 |
Why?
| | Cell Culture Techniques | 1 | 2005 | 363 | 0.050 |
Why?
| | Movement | 1 | 2004 | 278 | 0.050 |
Why?
| | Antigens, Neoplasm | 1 | 2005 | 319 | 0.050 |
Why?
| | Genotype | 1 | 2007 | 1916 | 0.050 |
Why?
| | Peroxidase | 1 | 2002 | 175 | 0.050 |
Why?
| | Dentistry | 1 | 2021 | 10 | 0.050 |
Why?
| | Dentin | 1 | 2021 | 24 | 0.050 |
Why?
| | Adaptation, Physiological | 2 | 2004 | 553 | 0.050 |
Why?
| | Chromatin Immunoprecipitation | 2 | 2013 | 138 | 0.050 |
Why?
| | Dentin-Bonding Agents | 1 | 2021 | 17 | 0.050 |
Why?
| | Dental Cements | 1 | 2021 | 20 | 0.050 |
Why?
| | Protein Binding | 3 | 2014 | 2224 | 0.050 |
Why?
| | Bisphenol A-Glycidyl Methacrylate | 1 | 2021 | 54 | 0.050 |
Why?
| | Tensile Strength | 1 | 2021 | 97 | 0.050 |
Why?
| | Pneumonia, Bacterial | 2 | 2013 | 116 | 0.040 |
Why?
| | Dental Materials | 1 | 2021 | 57 | 0.040 |
Why?
| | Iraq | 1 | 2021 | 53 | 0.040 |
Why?
| | Afghanistan | 1 | 2021 | 71 | 0.040 |
Why?
| | Amoxicillin-Potassium Clavulanate Combination | 1 | 2020 | 16 | 0.040 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2020 | 60 | 0.040 |
Why?
| | Signal Transduction | 4 | 2010 | 5079 | 0.040 |
Why?
| | Bacterial Capsules | 2 | 2002 | 30 | 0.040 |
Why?
| | Bacteremia | 1 | 2002 | 214 | 0.040 |
Why?
| | Drug Combinations | 1 | 2021 | 343 | 0.040 |
Why?
| | Mutagenesis, Insertional | 4 | 2008 | 65 | 0.040 |
Why?
| | Random Allocation | 1 | 2020 | 353 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2005 | 1242 | 0.040 |
Why?
| | Mucus | 2 | 2006 | 79 | 0.040 |
Why?
| | Plankton | 1 | 2019 | 6 | 0.040 |
Why?
| | Dermis | 1 | 2019 | 33 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2022 | 549 | 0.040 |
Why?
| | Intention to Treat Analysis | 1 | 2019 | 73 | 0.040 |
Why?
| | Gases | 1 | 2019 | 48 | 0.040 |
Why?
| | Pruritus | 1 | 2019 | 63 | 0.040 |
Why?
| | Chlorine | 1 | 2019 | 61 | 0.040 |
Why?
| | Equipment Contamination | 1 | 2019 | 67 | 0.040 |
Why?
| | Osmolar Concentration | 2 | 1997 | 171 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 976 | 0.040 |
Why?
| | Immunocompromised Host | 1 | 2020 | 202 | 0.040 |
Why?
| | Epidermis | 1 | 2019 | 157 | 0.040 |
Why?
| | Salvage Therapy | 1 | 2019 | 142 | 0.040 |
Why?
| | Transplantation, Autologous | 1 | 2019 | 238 | 0.040 |
Why?
| | Injury Severity Score | 1 | 2020 | 522 | 0.040 |
Why?
| | Consciousness Disorders | 1 | 2018 | 20 | 0.040 |
Why?
| | Animals, Newborn | 1 | 2020 | 844 | 0.040 |
Why?
| | Soot | 1 | 2018 | 26 | 0.040 |
Why?
| | Proteomics | 3 | 2010 | 1111 | 0.040 |
Why?
| | Facial Injuries | 1 | 2018 | 21 | 0.040 |
Why?
| | Smoke Inhalation Injury | 1 | 2018 | 28 | 0.040 |
Why?
| | Hypercapnia | 1 | 2018 | 53 | 0.040 |
Why?
| | Trauma Centers | 1 | 2020 | 421 | 0.030 |
Why?
| | Edema | 1 | 2018 | 130 | 0.030 |
Why?
| | Respiratory Sounds | 1 | 2018 | 125 | 0.030 |
Why?
| | Adhesins, Bacterial | 2 | 2010 | 40 | 0.030 |
Why?
| | Cloning, Molecular | 2 | 1995 | 534 | 0.030 |
Why?
| | Laryngoscopy | 1 | 2018 | 109 | 0.030 |
Why?
| | Mice, Inbred BALB C | 2 | 2011 | 1272 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2024 | 3412 | 0.030 |
Why?
| | Adult | 4 | 2021 | 37929 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2020 | 1509 | 0.030 |
Why?
| | Mutagenesis | 2 | 1994 | 179 | 0.030 |
Why?
| | Male | 6 | 2020 | 67762 | 0.030 |
Why?
| | Drosophila | 1 | 2017 | 154 | 0.030 |
Why?
| | Deglutition Disorders | 1 | 2018 | 143 | 0.030 |
Why?
| | Periplasmic Proteins | 1 | 1996 | 4 | 0.030 |
Why?
| | Sulfur Radioisotopes | 1 | 1995 | 15 | 0.030 |
Why?
| | Polyvinyl Alcohol | 1 | 2015 | 18 | 0.030 |
Why?
| | Chemical Precipitation | 1 | 1995 | 37 | 0.030 |
Why?
| | Open Reading Frames | 1 | 1996 | 123 | 0.030 |
Why?
| | Fibroblasts | 1 | 2021 | 996 | 0.030 |
Why?
| | Electrolytes | 1 | 2015 | 58 | 0.030 |
Why?
| | Chronic Disease | 2 | 2019 | 1793 | 0.030 |
Why?
| | Biomass | 1 | 2015 | 118 | 0.030 |
Why?
| | DNA Primers | 1 | 1996 | 515 | 0.030 |
Why?
| | Isotope Labeling | 1 | 1995 | 81 | 0.030 |
Why?
| | Solubility | 1 | 2015 | 245 | 0.030 |
Why?
| | Serine Endopeptidases | 1 | 1996 | 123 | 0.030 |
Why?
| | Logistic Models | 1 | 2020 | 2074 | 0.030 |
Why?
| | Odds Ratio | 1 | 2018 | 1070 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 4 | 1997 | 385 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2015 | 181 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2020 | 827 | 0.030 |
Why?
| | Genes, Suppressor | 1 | 1994 | 5 | 0.030 |
Why?
| | RNA, Bacterial | 1 | 1995 | 190 | 0.030 |
Why?
| | Rats | 1 | 2023 | 5647 | 0.030 |
Why?
| | Lethal Dose 50 | 2 | 2008 | 15 | 0.030 |
Why?
| | Nitrogen Oxides | 1 | 2014 | 55 | 0.030 |
Why?
| | Agar | 1 | 2013 | 12 | 0.030 |
Why?
| | Incidence | 1 | 2020 | 2804 | 0.030 |
Why?
| | Biomarkers | 1 | 2005 | 4149 | 0.030 |
Why?
| | Middle Aged | 3 | 2020 | 33479 | 0.030 |
Why?
| | United States | 2 | 2021 | 14841 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2014 | 269 | 0.030 |
Why?
| | Escherichia coli Proteins | 1 | 1995 | 200 | 0.030 |
Why?
| | Temperature | 1 | 1996 | 679 | 0.030 |
Why?
| | Keratinocytes | 1 | 2014 | 249 | 0.030 |
Why?
| | Reactive Oxygen Species | 4 | 1997 | 622 | 0.020 |
Why?
| | Drug Tolerance | 1 | 2013 | 105 | 0.020 |
Why?
| | Protein Multimerization | 1 | 2014 | 192 | 0.020 |
Why?
| | Gene Knockout Techniques | 1 | 2013 | 118 | 0.020 |
Why?
| | Fermentation | 1 | 2012 | 26 | 0.020 |
Why?
| | Immunoblotting | 1 | 2013 | 308 | 0.020 |
Why?
| | Young Adult | 2 | 2020 | 13209 | 0.020 |
Why?
| | Kinetics | 1 | 2015 | 1670 | 0.020 |
Why?
| | Collagen | 1 | 2014 | 452 | 0.020 |
Why?
| | Histidine Kinase | 1 | 2011 | 34 | 0.020 |
Why?
| | Genetic Variation | 1 | 1997 | 991 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2002 | 5757 | 0.020 |
Why?
| | Viral Plaque Assay | 1 | 2011 | 31 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2020 | 15657 | 0.020 |
Why?
| | Transcriptome | 1 | 2017 | 971 | 0.020 |
Why?
| | Denitrification | 1 | 2010 | 5 | 0.020 |
Why?
| | Ecological Systems, Closed | 1 | 2010 | 5 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 1994 | 1353 | 0.020 |
Why?
| | Hypoxia | 1 | 2018 | 1112 | 0.020 |
Why?
| | Lectins | 1 | 2010 | 49 | 0.020 |
Why?
| | Acute Disease | 1 | 2013 | 1007 | 0.020 |
Why?
| | Salmonella enterica | 1 | 2010 | 57 | 0.020 |
Why?
| | Adolescent | 2 | 2020 | 21513 | 0.020 |
Why?
| | Oxidative Stress | 1 | 1996 | 1317 | 0.020 |
Why?
| | 4-Butyrolactone | 1 | 2009 | 21 | 0.020 |
Why?
| | Oleic Acid | 1 | 2009 | 40 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2020 | 2069 | 0.020 |
Why?
| | DNA Restriction Enzymes | 1 | 1988 | 52 | 0.020 |
Why?
| | Electrophoresis, Agar Gel | 1 | 1988 | 26 | 0.020 |
Why?
| | Ions | 1 | 2008 | 70 | 0.020 |
Why?
| | Membrane Proteins | 1 | 1995 | 1164 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2009 | 375 | 0.020 |
Why?
| | Bacteriophage Pf1 | 1 | 2008 | 2 | 0.020 |
Why?
| | Weightlessness Simulation | 1 | 2007 | 7 | 0.020 |
Why?
| | Pregnancy | 1 | 2020 | 6763 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2008 | 144 | 0.020 |
Why?
| | Models, Molecular | 1 | 1993 | 1570 | 0.020 |
Why?
| | RNA, Messenger | 1 | 1995 | 2833 | 0.020 |
Why?
| | Nitrates | 1 | 2008 | 92 | 0.020 |
Why?
| | Salmonella Infections, Animal | 1 | 2007 | 38 | 0.020 |
Why?
| | DNA Transposable Elements | 1 | 2008 | 121 | 0.020 |
Why?
| | Spectrum Analysis | 1 | 2007 | 91 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2009 | 861 | 0.020 |
Why?
| | Molecular Weight | 2 | 1997 | 335 | 0.020 |
Why?
| | Oxygen | 1 | 2010 | 931 | 0.020 |
Why?
| | Viral Proteins | 1 | 2008 | 342 | 0.010 |
Why?
| | Genetic Complementation Test | 2 | 1995 | 67 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2019 | 10811 | 0.010 |
Why?
| | Neutrophils | 1 | 2010 | 1238 | 0.010 |
Why?
| | Hot Temperature | 2 | 1997 | 391 | 0.010 |
Why?
| | Sputum | 1 | 2006 | 311 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2011 | 3015 | 0.010 |
Why?
| | Morphogenesis | 2 | 1994 | 166 | 0.010 |
Why?
| | Respiratory Mucosa | 1 | 2006 | 321 | 0.010 |
Why?
| | Colony Count, Microbial | 1 | 2003 | 120 | 0.010 |
Why?
| | Electric Impedance | 1 | 2003 | 107 | 0.010 |
Why?
| | Proteins | 1 | 1988 | 1009 | 0.010 |
Why?
| | Sequence Analysis, DNA | 2 | 1997 | 812 | 0.010 |
Why?
| | Cell Wall | 1 | 2002 | 54 | 0.010 |
Why?
| | Bacterial Toxins | 1 | 2002 | 106 | 0.010 |
Why?
| | Bacterial Infections | 1 | 2002 | 250 | 0.010 |
Why?
| | Polymers | 1 | 2003 | 490 | 0.010 |
Why?
| | Nitrogen | 1 | 2000 | 168 | 0.010 |
Why?
| | Lipopolysaccharides | 1 | 2002 | 886 | 0.010 |
Why?
| | Aged | 1 | 2018 | 23961 | 0.010 |
Why?
| | Sodium Chloride | 1 | 1997 | 142 | 0.010 |
Why?
| | Suppression, Genetic | 1 | 1996 | 25 | 0.010 |
Why?
| | Transformation, Bacterial | 1 | 1995 | 8 | 0.010 |
Why?
| | Oligodeoxyribonucleotides | 1 | 1993 | 143 | 0.010 |
Why?
| | Recombination, Genetic | 1 | 1993 | 204 | 0.010 |
Why?
| | Infant | 1 | 2006 | 9465 | 0.010 |
Why?
| | Models, Genetic | 1 | 1994 | 600 | 0.010 |
Why?
| | Child, Preschool | 1 | 2006 | 11074 | 0.010 |
Why?
| | Alleles | 1 | 1993 | 891 | 0.010 |
Why?
| | Respiratory Tract Infections | 1 | 1993 | 390 | 0.000 |
Why?
| | Child | 1 | 2006 | 21935 | 0.000 |
Why?
|
|
Schurr's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|